Inhibitory effect of a novel Curcumin derivative DMC-HA on keloid fibroblasts
Aging · 2024
DOI: 10.18632/aging.205487 ↗At a glance
Journal article in Aging, 2024. Written by Liang Hu and 1 co-authors. Institution: Department of Burns and Plastic Surgery, Kunshan Hospital Affiliated to Jiangsu University, Kunshan 215300, Jiangsu, China. Major MEDLINE topics: Curcumin, Keloid. Cited 1 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.
Abstract (original language)
Keloids pose a significant dermatological challenge, marked by abnormal fibroblast proliferation and excessive collagen deposition in response to skin injury or trauma. In the present study, we introduce DMC-HA, a derivative of Curcumin, as a promising candidate for keloid treatment. DMC-HA is poised to provide superior therapeutic benefits compared to Curcumin due to its structural modifications. Examining the comparative effects of DMC-HA and Curcumin on keloid fibroblasts can offer insights into their potential as therapeutic agents and the underlying mechanisms in keloid pathogenesis. In our study, CCK-8 experiments revealed that, at equivalent concentrations, DMC-HA demonstrated greater efficacy in inhibiting the proliferation of keloid fibroblasts compared to Curcumin. Flow cytometry analysis indicated that DMC-HA induced fibroblast apoptosis more significantly than Curcumin at the same concentration. Further data demonstrated that DMC-HA notably increased the production of reactive oxygen species (ROS), upregulated the expression levels of Bax, cleaved PARP, and cleaved Caspase-3. Interestingly, the impact of DMC-HA was reversed upon the application of the antioxidant NAC. Additionally, DMC-HA could suppress IL-6-induced increased expression of p-STAT3. Collectively, our findings suggest that DMC-HA is more effective than Curcumin in inhibiting the proliferation of keloid fibroblasts. The underlying mechanism of its action appears to be associated with the augmentation of ROS induction and the concurrent inhibition of STAT3 activation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Burns and Plastic Surgery, Kunshan Hospital Affiliated to Jiangsu University, Kunshan 215300, Jiangsu, China.
- Department of Rehabilitation Medicine, Kunshan Hospital Affiliated to Jiangsu University, Kunshan 215300, Jiangsu, China.
Cite
APA
Hu, L., & Bao, Z. (2024). Inhibitory effect of a novel Curcumin derivative DMC-HA on keloid fibroblasts. Aging. https://doi.org/10.18632/aging.205487
Vancouver
Hu L, Bao Z. Inhibitory effect of a novel Curcumin derivative DMC-HA on keloid fibroblasts. Aging. 2024. doi:10.18632/aging.205487
BibTeX
@article{Hu2024,
author = {Hu, Liang and Bao, Zhicheng},
title = {Inhibitory effect of a novel Curcumin derivative DMC-HA on keloid fibroblasts},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205487}
}
EUVIMED